Bovis Homes Group Stock Rating Reaffirmed by Deutsche Bank (BVS)

Bovis Homes Group (LON: BVS)‘s stock had its “buy” rating restated by equities research analysts at Deutsche Bank in a research note issued to investors on Tuesday, AnalystRatings.Net reports. They currently have a GBX 878 ($13.79) target price on the stock, up from their previous target price of GBX 863 ($13.55). Deutsche Bank’s price objective suggests a potential upside of 14.03% from the stock’s previous close.

Shares of Bovis Homes Group (LON: BVS) opened at 770.50 on Tuesday. Bovis Homes Group has a 52 week low of GBX 426.50 and a 52 week high of GBX 783.63. The stock’s 50-day moving average is currently GBX 501.4. The company’s market cap is £1.032 billion.

BVS has been the subject of a number of other recent research reports. Analysts at Jefferies Group reiterated a “buy” rating on shares of Bovis Homes Group in a research note to investors on Monday, June 10th. They now have a GBX 897 ($14.09) price target on the stock. Separately, analysts at HSBC reiterated an “overweight” rating on shares of Bovis Homes Group in a research note to investors on Friday, June 7th. They now have a GBX 950 ($14.92) price target on the stock. Finally, analysts at Citigroup reiterated a “neutral” rating on shares of Bovis Homes Group in a research note to investors on Wednesday, June 5th. They now have a GBX 820 ($12.88) price target on the stock, up previously from GBX 710 ($11.15).

Seven research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of GBX 793.46 ($12.46).

Bovis Homes Group PLC is a builder of traditional homes in England and Wales. The Company’s business involves the designing, building and selling of new homes for both private and public sector customers.

Latest News

$65.06 Million in Sales Expected for TPG Specialty Lending Inc  This Quarter
$65.06 Million in Sales Expected for TPG Specialty Lending Inc This Quarter
EncryptoTel [ETH]  Reaches One Day Volume of $10,783.00
EncryptoTel [ETH] Reaches One Day Volume of $10,783.00
CrowdWiz   Trading 16.1% Lower  This Week
CrowdWiz Trading 16.1% Lower This Week
Revance Therapeutics Inc  Expected to Post Quarterly Sales of $1.74 Million
Revance Therapeutics Inc Expected to Post Quarterly Sales of $1.74 Million
Recro Pharma Inc  Expected to Post Earnings of -$0.75 Per Share
Recro Pharma Inc Expected to Post Earnings of -$0.75 Per Share
Analysts Anticipate Paylocity Holding Corp  to Announce $0.24 Earnings Per Share
Analysts Anticipate Paylocity Holding Corp to Announce $0.24 Earnings Per Share


© 2006-2018 Ticker Report